Study Stopped
Per discretion of Sponsor.
Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")
CHAT
Avocado Voucher Impact on Health Outcomes in Hispanic/Latino Adults With or At-risk of Type 2 Diabetes
1 other identifier
interventional
50
1 country
1
Brief Summary
Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino (predominantly of Mexican origin) adults with or at-risk of T2D before and after receiving free avocados for 12 weeks. Beyond CGM-measured glycemic control, wearable activity and sleep monitors, physical exams, laboratory analyses, and questionnaires/logs will be used to track the impact of free avocado vouchers. The findings are anticipated to help clinicians provide new information to support positive behavior change to reduce the risk of T2D or progression from pre-diabetes to T2D and make it easier for patients to access healthier food, potentially leading to improved health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedStudy Start
First participant enrolled
March 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedNovember 30, 2023
November 1, 2023
10 months
December 22, 2021
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time in range (TIR) between 140 and 180 mg/dL [TIR (140-180)]- Change from Prior to Intervention, to Final Two Weeks of Intervention
TIR (140 -180 mg/dL) between 6 am and 12 am (waking hours).
Prior to Intervention (Week 0), and During Final 2 Weeks of Intervention (Week 13 or 14)
Secondary Outcomes (27)
Waist Circumference- Change from Enrollment Visit to Study Conclusion Visit
At Enrollment Visit and at 14 weeks from Enrollment Visit
Blood Pressure- Diastolic and Systolic- Change from Enrollment Visit to Study Conclusion Visit
At Enrollment visit and at 14 weeks from Enrollment Visit
HbA1c- Change from Enrollment Visit to Study Conclusion Visit
At Enrollment Visit and at 14 weeks from Enrollment Visit
Insulin resistance- Change from Enrollment Visit to Study Conclusion Visit
At Enrollment visit and at 14 weeks from enrollment visit
Lipids- Change from Enrollment Visit to Study Conclusion Visit
At enrollment visit and at 14 weeks from enrollment visit
- +22 more secondary outcomes
Study Arms (2)
Hispanic/Latino adults with or at risk of T2D- Active Group
EXPERIMENTALEligible participants receive vouchers for free avocados.
Hispanic/Latino adults with or at risk of T2D- Control Group
NO INTERVENTIONEligible participants will not receive vouchers for free avocados.
Interventions
Food as Medicine to demonstrate clinically meaningful benefits for underserved communities. Avocados are fruits with fats, fiber, micronutrients, and bioactive phytochemicals.
Eligibility Criteria
You may qualify if:
- Adults ≥ 18 years of age at enrollment.
- Self-reported Hispanic/Latino heritage.
- Self-reported diagnosis of T2D or self-reported as at risk for developing T2D using the American Diabetes Association diabetes risk assessment tool \[25\].
You may not qualify if:
- Use of insulin
- Pregnancy
- Any active clinically significant disease or disorder which in the investigator's opinion could interfere with participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sansum Diabetes Research Institutelead
- Hass Avocado Boardcollaborator
Study Sites (1)
Sansum Diabetes Research Institute
Santa Barbara, California, 93105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Kerr, MBChB
Sansum Diabetes Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2021
First Posted
March 24, 2022
Study Start
March 31, 2022
Primary Completion
January 31, 2023
Study Completion
January 31, 2023
Last Updated
November 30, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share